Adaptive Bio Ownership | Who Owns Adaptive Bio?


OverviewForecastRevenueFinancialsChartTranscripts

Adaptive Bio Ownership Summary


Adaptive Bio is owned by 97.08% institutional investors, 1.92% insiders, and 1.00% retail investors. Viking global investors lp is the largest institutional shareholder, holding 20.33% of ADPT shares. ARK Genomic Revolution is the top mutual fund, with 6.30% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAdaptive Bio97.08%1.92%1.00%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp29.99M20.33%$179.81M
Rubric capital management lp14.60M9.90%$87.53M
Blackrock funding, inc. /de12.12M8.22%$72.66M
Vanguard group10.71M7.26%$64.24M
Ark investment management9.42M6.39%$56.50M
Sumitomo mitsui trust6.83M4.63%$40.96M
Nikko asset management americas6.83M4.63%$40.93M
Millennium management6.29M4.27%$37.72M
Massachusetts financial services co /ma/3.37M2.29%$20.21M
Soleus capital management2.98M2.02%$17.88M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue water life science advisors, lp2.15M11.39%$12.86M
Soleus capital management2.98M1.12%$17.88M
Rubric capital management lp14.60M1.12%$87.53M
Pier capital1.27M1.09%$7.64M
Essex investment management625.84K0.67%$3.75M
Viking global investors lp29.99M0.58%$179.81M
Aristotle atlantic partners2.89M0.54%$17.31M
Ark investment management9.42M0.47%$56.50M
Clearline capital lp586.78K0.47%$3.52M
Nikko asset management americas6.83M0.44%$40.93M

Top Buyers

HolderShares% AssetsChange
Voya investment management2.43M0.02%2.39M
Soleus capital management2.98M1.12%1.87M
Ameriprise financial736.72K0.00%654.31K
Deutsche bank ag\630.58K0.00%503.84K
Massachusetts financial services co /ma/3.37M0.01%489.56K

Top Sellers

HolderShares% AssetsChange
Millennium management6.29M0.02%-3.11M
Ark investment management9.42M0.47%-2.18M
Pictet asset management sa26.94K0.00%-1.27M
Nikko asset management americas6.83M0.44%-900.75K
Sumitomo mitsui trust6.83M0.03%-900.75K

New Positions

HolderShares% AssetsChangeValue
Exoduspoint capital management, lp246.87K0.01%246.87K$1.48M
Cinctive capital management lp241.32K0.07%241.32K$1.45M
Swiss national bank203.10K0.00%203.10K$1.22M
Trexquant investment lp185.87K0.01%185.87K$1.11M
Caxton associates lp123.29K0.02%123.29K$739.11K

Sold Out

HolderChange
Northwestern mutual wealth management-24.00
Srs capital advisors-97.00
Bokf, na-116.00
Capital performance advisors llp-764.00
Group one trading-1.62K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202420911.17%143,202,0650.07%971.03%11114.43%452.27%
Sep 30, 20241886.21%143,105,692-3.74%970.93%975.43%44-4.35%
Jun 30, 2024177-7.81%148,665,2304.35%1011.07%926.98%46-30.30%
Mar 31, 2024192-4.48%142,469,885-0.71%970.99%86-10.42%66-8.33%
Dec 31, 20232014.69%143,483,8981.57%991.04%9626.32%72-1.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Genomic Revolution9.30M6.30%-2.22M
ARK Genomic Revolution ETF7.46M5.02%287.42K
Nikko AM ARK Pstv Chg Innovt P JPY Acc4.93M3.32%-152.74K
Vanguard Total Stock Mkt Idx Inv4.49M3.02%-
Vanguard US Total Market Shares ETF4.19M2.82%-
iShares Russell 2000 ETF3.05M2.05%-26.45K
MFS New Discovery I2.20M1.48%-
Columbia Small Cap Growth Inst2.09M1.41%216.00K
Nikko Gbl All Biological Genome Eq MF2.06M1.40%-121.82K
Vanguard Small Cap Index1.79M1.20%1.46K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 24, 2025ROBINS HARLAN S Chief Scientific OfficerSell$15.28K
Mar 13, 2025GRIFFIN MICHELLE RENEE-Sell$260.93K
Mar 12, 2025HERSHBERG ROBERT-Sell$402.27K
Mar 10, 2025NEUPERT PETER M-Sell$70.50K
Mar 05, 2025LO FRANCIS Chief People OfficerSell$96.39K

Insider Transactions Trends


DateBuySell
2025 Q1-25
2024 Q4-1
2024 Q3-1
2024 Q2--
2024 Q1-14

ADPT Ownership FAQ


Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 97.08%, followed by 1.92% insiders and 1.00% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 68.48%, which Adaptive Bio exceeds.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 20.33%), Rubric capital management lp (14.6M shares, 9.90%), and Blackrock funding, inc. /de (12.12M shares, 8.22%). Together, they hold 38.45% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

BlackRock is not among the top 10 institutional shareholders of Adaptive Bio.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Blue water life science advisors, lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 11.39% of its assets in 2.15M Adaptive Bio shares, valued at 12.86M$.

Who is the top mutual fund holder of Adaptive Bio shares?

ARK Genomic Revolution is the top mutual fund holder of Adaptive Bio shares, with 6.30% of its total shares outstanding invested in 9.3M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools